Oramed Pharmaceuticals OTC:ORMP.OB is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an oral insulin capsule currently in Phase trials, the Company is seeking to revolutionize the treatment of diabetes.
Quote | Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)
Last: | $2.56 |
---|---|
Change Percent: | 0.0% |
Open: | $2.54 |
Close: | $2.56 |
High: | $2.575 |
Low: | $2.54 |
Volume: | 74,575 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)
2024-06-26 09:15:35 ET More on Oramed Pharmaceuticals Seeking Alpha’s Quant Rating on Oramed Pharmaceuticals Historical earnings data for Oramed Pharmaceuticals Financial information for Oramed Pharmaceuticals Read the full article on Seeking Alpha ...
2024-05-05 08:00:00 ET As Wall Street embarks on the first full week of May, a diverse group of companies is set to report financial results. Notable names include The Walt Disney Company ( NYSE: DIS ), Palantir Technologies ( NYSE: PLTR ), Realty Income ( NYSE: ...
Message Board Posts | Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)
Subject | By | Source | When |
---|---|---|---|
I agree - I will be happy if | Amatuer17 | investorshub | 05/15/2023 2:49:52 PM |
I am completely out of this stock | midastouch017 | investorshub | 05/15/2023 2:42:47 PM |
That is good news for Oramed - not | Amatuer17 | investorshub | 05/15/2023 2:38:29 PM |
3.8200+0.9900 (+34.9823%) | midastouch017 | investorshub | 05/15/2023 1:51:05 PM |
Oramed Announces that its Chinese Partner, HTIT, has | midastouch017 | investorshub | 05/15/2023 1:22:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Oramed Pharmaceuticals Inc. Company Name:
ORMP Stock Symbol:
NASDAQ Market:
Oramed Pharmaceuticals Inc. Website:
PALO ALTO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today...
Crescent Energy Company Class A (CRGY) is expected to report $0.21 for Q4 2023 ThredUp Inc. (TDUP) is expected to report $-0.13 for Q4 2023 Wright Investors` Service Holdings Inc (IWSH) is expected to report for Q4 2023 Bridgford Foods Corporation (BRID) is expected to report for Q1 2...